Pieter M. Kolijn

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Detailed immunophenotypic and genetic characterization of bone marrow clonal plasma cells and B-cells in early-stage monoclonal gammopathies.

Detailed immunophenotypic and genetic characterization of bone marrow clonal plasma cells and B-cells in early-stage monoclonal gammopathies.

Journal: Blood cancer journal

Published: April 20, 2026

Identifying Plasma Proteins Associated with Risk of Solid Cancers: A 25-Year Prospective Analysis of 4,712 Circulating Proteins in the ARIC Study.

Identifying Plasma Proteins Associated with Risk of Solid Cancers: A 25-Year Prospective Analysis of 4,712 Circulating Proteins in the ARIC Study.

Journal: medRxiv : the preprint server for health sciences

Published: March 27, 2026

Immune Markers and Risk of Pancreatic Cancer in the European EPIC Cohort.

Immune Markers and Risk of Pancreatic Cancer in the European EPIC Cohort.

Journal: International journal of cancer

Published: February 10, 2026

Serum Biomarkers Linked to Disease Activity, Severity, and Methylprednisolone Response in Graves' Orbitopathy: A Proteomic Study.

Serum Biomarkers Linked to Disease Activity, Severity, and Methylprednisolone Response in Graves' Orbitopathy: A Proteomic Study.

Journal: Investigative ophthalmology & visual science

Published: November 14, 2025

Circulating levels of insulin-like growth factor I (IGF-I) and risk of multiple myeloma: An observational and Mendelian randomisation study.

Circulating levels of insulin-like growth factor I (IGF-I) and risk of multiple myeloma: An observational and Mendelian randomisation study.

Journal: British journal of haematology

Published: November 05, 2025

Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvement.

Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvement.

Journal: Research square

Published: September 15, 2025

Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvement.

Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvement.

Journal: medRxiv : the preprint server for health sciences

Published: September 05, 2025

Multi-Cohort High-Dimensional Proteomics Reveals Early Risk Markers for Lymphoid Cancer Subtypes.

Multi-Cohort High-Dimensional Proteomics Reveals Early Risk Markers for Lymphoid Cancer Subtypes.

Journal: Research square

Published: September 02, 2025

Large-scale plasma proteomics uncovers preclinical molecular signatures of Parkinson's disease and overlap with other neurodegenerative disorders.

Large-scale plasma proteomics uncovers preclinical molecular signatures of Parkinson's disease and overlap with other neurodegenerative disorders.

Journal: medRxiv : the preprint server for health sciences

Published: August 06, 2025

Plasma signals of lung tumor promotion for molecular cancer prevention.

Plasma signals of lung tumor promotion for molecular cancer prevention.

Journal: Cell

Published: July 04, 2025

Multi-cohort high-dimensional proteomics reveals early risk markers for lymphoid cancer subtypes.

Multi-cohort high-dimensional proteomics reveals early risk markers for lymphoid cancer subtypes.

Journal: Nature communications

Published: June 05, 2025

A smoking-related plasma protein score and smoking-related cancer risk and mortality in the Atherosclerosis Risk in Communities study.

A smoking-related plasma protein score and smoking-related cancer risk and mortality in the Atherosclerosis Risk in Communities study.

Journal: Journal of the National Cancer Institute

Published: May 08, 2025

Showing 1-12 of 39

Last Updated: 09/26/2026